TAM
VYNT

Tocqueville Asset Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Tocqueville Asset Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$20K – 844
2016
Q4 		$20K Sell
100
-59
-37% -$13.4K ﹤0.01% 795
2016
Q3 		$42K Hold
159
– – ﹤0.01% 813
2016
Q2 		$47K Sell
159
-36
-18% -$12.7K ﹤0.01% 825
2016
Q1 		$83K Sell
195
-125
-39% -$46.8K ﹤0.01% 839
2015
Q4 		$158K Buy
+320
New +$231K ﹤0.01% 866

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tocqueville Asset Management's VYNT Position: Q1 2017 in Review

Tocqueville Asset Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2017, closing a stake of 100 shares — an estimated $20K sold.

Tocqueville Asset Management first reported a position in VYNT in Q4 2015 and held it in 5 quarters. The position peaked at $158K in Q4 2015. 32 funds tracked by Wall St. Rank hold VYNT as of Q1 2017.

  • Tocqueville Asset Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Tocqueville Asset Management sold 100 Vyant Bio, Inc. Common Stock shares in Q1 2017, an estimated $20K.
  • Tocqueville Asset Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • Tocqueville Asset Management's Vyant Bio, Inc. Common Stock position peaked at $158K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2017.

Based on Tocqueville Asset Management's 13F filing for Q1 2017, filed 28 Apr 2017.